Lapidot A - Search Results

1

NeoR6 inhibits HIV-1-CXCR4 interaction without affecting CXCL12 chemotaxis activity.

Lapidot A, Peled A, Berchanski A, Pal B, Kollet O, Lapidot T, Borkow G. Lapidot A, et al. Biochim Biophys Acta. 2008 Jun;1780(6):914-20. doi: 10.1016/j.bbagen.2008.03.011. Epub 2008 Mar 21. Biochim Biophys Acta. 2008. PMID: 18410746

2

Prediction of HIV-1 entry inhibitors neomycin-arginine conjugates interaction with the CD4-gp120 binding site by molecular modeling and multistep docking procedure.

Berchanski A, Lapidot A. Berchanski A, et al. Among authors: lapidot a. Biochim Biophys Acta. 2007 Sep;1768(9):2107-19. doi: 10.1016/j.bbamem.2007.04.017. Epub 2007 May 1. Biochim Biophys Acta. 2007. PMID: 17560540 Free article.

3

Structure-function relationship of novel X4 HIV-1 entry inhibitors - L- and D-arginine peptide-aminoglycoside conjugates.

Hegde R, Borkow G, Berchanski A, Lapidot A. Hegde R, et al. Among authors: lapidot a. FEBS J. 2007 Dec;274(24):6523-36. doi: 10.1111/j.1742-4658.2007.06169.x. Epub 2007 Nov 20. FEBS J. 2007. PMID: 18028446 Free article.

4

Bacterial RNase P RNA is a drug target for aminoglycoside-arginine conjugates.

Berchanski A, Lapidot A. Berchanski A, et al. Among authors: lapidot a. Bioconjug Chem. 2008 Sep;19(9):1896-906. doi: 10.1021/bc800191u. Epub 2008 Aug 20. Bioconjug Chem. 2008. PMID: 18712898

5

Insight into the mechanisms of aminoglycoside derivatives interaction with HIV-1 entry steps and viral gene transcription.

Lapidot A, Berchanski A, Borkow G. Lapidot A, et al. FEBS J. 2008 Nov;275(21):5236-57. doi: 10.1111/j.1742-4658.2008.06657.x. Epub 2008 Sep 18. FEBS J. 2008. PMID: 18803669 Free article. Review.

6

Computer-based design of novel HIV-1 entry inhibitors: neomycin conjugated to arginine peptides at two specific sites.

Berchanski A, Lapidot A. Berchanski A, et al. Among authors: lapidot a. J Mol Model. 2009 Mar;15(3):281-94. doi: 10.1007/s00894-008-0401-1. Epub 2008 Dec 5. J Mol Model. 2009. PMID: 19057930

7

Insights into the mechanism of enhanced mobilization of hematopoietic progenitor cells and release of CXCL12 by a combination of AMD3100 and aminoglycoside-polyarginine conjugates.

Berchanski A, Kalinkovich A, Ludin A, Lapidot T, Lapidot A. Berchanski A, et al. Among authors: lapidot a. FEBS J. 2011 Nov;278(21):4150-65. doi: 10.1111/j.1742-4658.2011.08348.x. Epub 2011 Oct 4. FEBS J. 2011. PMID: 21910828 Free article.

8

Structure-activity relationship of neomycin, paromomycin, and neamine-arginine conjugates, targeting HIV-1 gp120-CXCR4 binding step.

Borkow G, Vijayabaskar V, Lara HH, Kalinkovich A, Lapidot A. Borkow G, et al. Among authors: lapidot a. Antiviral Res. 2003 Nov;60(3):181-92. doi: 10.1016/s0166-3542(03)00156-6. Antiviral Res. 2003. PMID: 14638394

9

Mutations in gp41 and gp120 of HIV-1 isolates resistant to hexa-arginine neomycin B conjugate.

Borkow G, Lara HH, Lapidot A. Borkow G, et al. Among authors: lapidot a. Biochem Biophys Res Commun. 2003 Dec 26;312(4):1047-52. doi: 10.1016/j.bbrc.2003.11.011. Biochem Biophys Res Commun. 2003. PMID: 14651977

10

Neomycin B-arginine conjugate, a novel HIV-1 Tat antagonist: synthesis and anti-HIV activities.

Litovchick A, Lapidot A, Eisenstein M, Kalinkovich A, Borkow G. Litovchick A, et al. Among authors: lapidot a. Biochemistry. 2001 Dec 25;40(51):15612-23. doi: 10.1021/bi0108655. Biochemistry. 2001. PMID: 11747436

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124 results

Search Page

Filters